INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Tue, 5 May · 19:00 IST

Ind-Swift Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

Board & Shareholder Meetings View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.1%1-day move
₹143.00
prior close
₹145.65
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.0-1.8-1.3-1.5-2.1-3.4-3.5-2.9-3.7-4.9-5.7+9.4+55.1
Up moveDown movePending
AI summary

Ind-Swift Laboratories Limited has disclosed the results of a postal ballot conducted via remote e-voting (April 1-30, 2026). Four Special Resolutions were passed with overwhelming shareholder approval (~99.87-99.88% in favour). Key outcomes: (1) Change in designation of Sh. N.R. Munjal, (2) Appointment of Sh. Himanshu Jain as Managing Director (Domestic Operations), (3) Appointment of Sh. Sahil Munjal as Managing Director (Global Operations), and (4) Payment of remuneration to Sh. Rishav Mehta as Whole-Time Director. Total votes polled: 36.16 million shares (41.65% turnout) out of 86.84 million outstanding. Promoter group voted 100% in favour across all resolutions. Public institutions accounted for minor against votes (~17% against) but overall results were decisive.

Likely market impact

Strong shareholder mandate for leadership changes and remuneration approval with near-unanimous support. The appointment of two new Managing Directors (Himanshu Jain and Sahil Munjal) suggests a structured transition in company leadership, with minimal market impact expected given the routine nature of the voting.